Portal de investigación
Oxidative Stress, a Crossroad Between Rare Diseases and Neurodegeneration.
Fecha de publicación:
Autores de CIPF
Participantes ajenos a CIPF
- García-Gimeno MA
- Sanz P
- Sevilla T
Grupos de Investigación
Abstract
Oxidative stress is an imbalance between production and accumulation of oxygen reactive species and/or reactive nitrogen species in cells and tissues, and the capacity of detoxifying these products, using enzymatic and non-enzymatic components, such as glutathione. Oxidative stress plays roles in several pathological processes in the nervous system, such as neurotoxicity, neuroinflammation, ischemic stroke, and neurodegeneration. The concepts of oxidative stress and rare diseases were formulated in the eighties, and since then, the link between them has not stopped growing. The present review aims to expand knowledge in the pathological processes associated with oxidative stress underlying some groups of rare diseases: Friedreich's ataxia, diseases with neurodegeneration with brain iron accumulation, Charcot-Marie-Tooth as an example of rare neuromuscular disorders, inherited retinal dystrophies, progressive myoclonus epilepsies, and pediatric drug-resistant epilepsies. Despite the discrimination between cause and effect may not be easy on many occasions, all these conditions are Mendelian rare diseases that share oxidative stress as a common factor, and this may represent a potential target for therapies.
Datos de la publicación
- ISSN/ISSNe:
- 2076-3921, 2076-3921
- Tipo:
- Article
- Páginas:
- -
- PubMed:
- 32326494
Antioxidants Multidisciplinary Digital Publishing Institute (MDPI)
Citas Recibidas en Web of Science: 44
Documentos
- No hay documentos
Filiaciones
Keywords
- Charcot-Marie-Tooth disease (CMT), Dravet syndrome, Friedreich’s ataxia, Lafora disease (LD), Unverricht–Lundborg disease (ULD), inherited retinal dystrophy (IRD), neurodegenerative disorders with brain iron accumulation (NBIA), progressive myoclonus epilepsy (PME)
Proyectos asociados
An integrative approach to develop cellular models and characterize disease mechanisms implicated in CMT2Z, a newly described axonal form of neuropathy
Investigador Principal: CARMEN ESPINÓS ARMERO
ASSOCIATION FRANÇAISE CONTRE LES MYOPATHIES . 2018
Estudios clínicos, bases genéticas y biomarcadores pronósticos en enfermedades raras neurodegenerativas
Investigador Principal: CARMEN ESPINÓS ARMERO
INSTITUTO DE SALUD CARLOS III . 2019
Desarrollo de nanoterapias anti-inflamatorias en retinosis pigmentaria
Investigador Principal: REGINA RODRIGO NICOLÁS
INSTITUTO DE SALUD CARLOS III . 2019
De genes a terapia en enfermedades neurodegenerativas y neuromusculares. Concedido a la UV
Investigador Principal: CARMEN ESPINÓS ARMERO
CONSELLERIA DE EDUCACION . 2018